Aspen Investment Management’s AbbVie ABBV Stock Holding History

Aspen Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47M	Buy	13,782 +503	+4%	+$108K	0.93%	26
2026 Q1	$2.89M	Buy	13,279 +502	+4%	+$111K	0.88%	26
2025 Q4	$2.92M	Buy	12,777 +7,047	+123%	+$1.61M	0.88%	25
2025 Q3	$1.33M	Buy	5,730 +907	+19%	+$185K	0.51%	60
2025 Q2	$895K	Buy	4,823 +290	+6%	+$53.9K	0.38%	72
2025 Q1	$950K	Buy	4,533 +277	+7%	+$53.9K	0.44%	68
2024 Q4	$756K	Sell	4,256 -830	-16%	-$153K	0.35%	75
2024 Q3	$1M	Hold	5,086	–	–	0.47%	64
2024 Q2	$872K	Sell	5,086 -50	-1%	-$8.28K	0.44%	68
2024 Q1	$935K	Buy	5,136 +130	+3%	+$22.4K	0.47%	62
2023 Q4	$776K	Buy	5,006 +1	+0%	+$146	0.43%	71
2023 Q3	$746K	Hold	5,005	–	–	0.45%	66
2023 Q2	$674K	Hold	5,005	–	–	0.4%	70
2023 Q1	$798K	Hold	5,005	–	–	0.51%	63
2022 Q4	$809K	Sell	5,005 -490	-9%	-$75.1K	0.53%	67
2022 Q3	$737K	Hold	5,495	–	–	0.49%	67
2022 Q2	$842K	Hold	5,495	–	–	0.53%	62
2022 Q1	$891K	Buy	5,495 +100	+2%	+$14.5K	0.47%	74
2021 Q4	$730K	Hold	5,395	–	–	0.36%	89
2021 Q3	$582K	Hold	5,395	–	–	0.31%	92
2021 Q2	$608K	Hold	5,395	–	–	0.32%	87
2021 Q1	$584K	Hold	5,395	–	–	0.33%	89
2020 Q4	$578K	Hold	5,395	–	–	0.34%	87
2020 Q3	$473K	Hold	5,395	–	–	0.32%	84
2020 Q2	$530K	Hold	5,395	–	–	0.38%	75
2020 Q1	$411K	Sell	5,395 -50	-0.9%	-$4.26K	0.36%	75
2019 Q4	$482K	Hold	5,445	–	–	0.3%	88
2019 Q3	$412K	Sell	5,445 -50	-0.9%	-$3.43K	0.28%	93
2019 Q2	$400K	Sell	5,495 -150	-3%	-$11.8K	0.26%	95
2019 Q1	$455K	Hold	5,645	–	–	0.32%	86
2018 Q4	$520K	Hold	5,645	–	–	0.42%	75
2018 Q3	$534K	Hold	5,645	–	–	0.35%	82
2018 Q2	$523K	Buy	5,645 +100	+2%	+$9.77K	0.36%	82
2018 Q1	$525K	Buy	5,545 +110	+2%	+$12.1K	0.38%	81
2017 Q4	$526K	Buy	5,435 +225	+4%	+$21.2K	0.37%	81
2017 Q3	$463K	Hold	5,210	–	–	0.34%	83
2017 Q2	$378K	Buy	5,210 +40	+0.8%	+$2.69K	0.28%	90
2017 Q1	$337K	Buy	5,170 +125	+2%	+$7.86K	0.25%	96
2016 Q4	$316K	Hold	5,045	–	–	0.24%	99
2016 Q3	$318K	Hold	5,045	–	–	0.25%	90
2016 Q2	$312K	Sell	5,045 -130	-3%	-$7.92K	0.26%	86
2016 Q1	$296K	Sell	5,175 -450	-8%	-$25.1K	0.27%	89
2015 Q4	$333K	Hold	5,625	–	–	0.33%	79
2015 Q3	$306K	Sell	5,625 -360	-6%	-$23.4K	0.3%	85
2015 Q2	$402K	Hold	5,985	–	–	0.34%	72
2015 Q1	$350K	Buy	5,985 +120	+2%	+$7.25K	0.28%	84
2014 Q4	$384K	Hold	5,865	–	–	0.32%	78
2014 Q3	$339K	Buy	5,865 +182	+3%	+$10.1K	0.28%	86
2014 Q2	$321K	Sell	5,683 -400	-7%	-$21K	0.2%	102
2014 Q1	$313K	Hold	6,083	–	–	0.2%	99
2013 Q4	$321K	Hold	6,083	–	–	0.21%	101
2013 Q3	$272K	Hold	6,083	–	–	0.19%	99
2013 Q2	$251K	Buy	+6,083	New	+$266K	0.17%	99

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Aspen Investment Management's ABBV Position: Q2 2026 in Review

Aspen Investment Management increased its AbbVie (ABBV) stake by 3.8% in Q2 2026, buying an estimated $108K and bringing the position to 13,782 shares worth $3.47M. The position accounts for 0.93% of the portfolio, ranked #26.

Aspen Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Aspen Investment Management held 13,782 shares of AbbVie worth $3.47M as of Q2 2026.
Aspen Investment Management bought 503 AbbVie shares in Q2 2026, an estimated $108K.
AbbVie made up 0.93% of Aspen Investment Management's portfolio in Q2 2026, its #26 holding.
Aspen Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.